Literature DB >> 25399242

Longitudinal follow-up of Riata leads reveals high annual incidence of new conductor externalization and electrical failure.

Christian Steinberg1, Jean-François Sarrazin, François Philippon, Jean Champagne, Marc-André Bouchard, Franck Molin, Isabelle Nault, Louis Blier, Gilles O'Hara.   

Abstract

BACKGROUND AND
PURPOSE: Riata(TM) defibrillation leads are susceptible to conductor externalization. The point prevalence of insulation defect in Riata(TM) leads is up to 33 %, but prospective data concerning incidence of new lead abnormalities are lacking. The purpose of our study was to determine the annual incidence of new conductor externalizations and electrical lead failure.
METHODS: A prospective observational study was conducted at a single tertiary center. One hundred forty-one patients were followed over 12 months. A posterior-anterior (PA)/lateral chest x-ray (CXR) with zooming was performed at baseline and at 12 months to screen for conductor externalization. Electrical abnormalities and clinical outcome were also assessed.
RESULTS: The overall incidence of new insulation defects was 8.5 % at 12 months. High-risk leads for new conductor externalization were lead models 1580, 1582, and 1590 with an annual rate of 11.9, 11.1, and 10 %, respectively. New conductor externalizations were three times more common in 8 Fr leads compared to 7 Fr leads. The overall incidence of new electrical dysfunction was 6.4 % at 12 months. Electrical dysfunction was significantly higher in abnormal leads (25 % [3/12], 4.7 % [6/129]; p = 0.03) and mostly driven by high ventricular pacing thresholds. There was no difference in inappropriate shock or failure of high-voltage therapy.
CONCLUSION: The annual incidence of new insulation defects in Riata(TM) leads is much higher than previously reported. Lead models 1580, 1582, and 1590 are at highest risk for new conductor externalization. Electrical dysfunction in Riata(TM) leads is also much higher than reported and is associated with conductor externalization.

Entities:  

Mesh:

Year:  2014        PMID: 25399242     DOI: 10.1007/s10840-014-9951-6

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  16 in total

1.  Prevalence of externalized conductors in Riata and Riata ST silicone leads: results from the prospective, multicenter Riata Lead Evaluation Study.

Authors:  David Hayes; Roger Freedman; Anne B Curtis; Mark Niebauer; G Neal Kay; Jay Dinerman; Scott Beau
Journal:  Heart Rhythm       Date:  2013-08-27       Impact factor: 6.343

2.  Riata lead failure with normal electrical lead parameters and normal fluoroscopic appearance.

Authors:  Umashankar Lakshmanadoss; David Lahoda; Pramod Deshmukh
Journal:  J Interv Card Electrophysiol       Date:  2012-10-19       Impact factor: 1.900

3.  Failure of implantable cardioverter-defibrillator leads: a matter of lead size?

Authors:  Roberto Rordorf; Luca Poggio; Simone Savastano; Alessandro Vicentini; Barbara Petracci; Enrico Chieffo; Catherine Klersy; Maurizio Landolina
Journal:  Heart Rhythm       Date:  2012-10-11       Impact factor: 6.343

4.  Mechanical and electrical dysfunction of Riata implantable cardioverter-defibrillator leads.

Authors:  Fatma Demirel; Ahmet Adiyaman; Peter Paul H M Delnoy; Jaap Jan J Smit; Anand R Ramdat Misier; Arif Elvan
Journal:  Europace       Date:  2014-05-19       Impact factor: 5.214

5.  Fluoroscopic screening of asymptomatic patients implanted with the recalled Riata lead family.

Authors:  Jeffrey Liu; Rohit Rattan; Evan Adelstein; William Barrington; Raveen Bazaz; Susan Brode; Sandeep Jain; G Stuart Mendenhall; Jan Nemec; Eathar Razak; Alaa Shalaby; David Schwartzman; Andrew Voigt; Norman C Wang; Samir Saba
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-07-11

6.  Prevalence and predictors of cable extrusion and loss of electrical integrity with the Riata defibrillator lead.

Authors:  Sharon Shen; Prashant Bhave; Evan Giedrimas; Taral Patel; Rishi Arora; Alexandru B Chicos; Jeffrey J Goldberger; Leonard Ilkhanoff; Michael H Kim; Albert C Lin; Rod Passman; Richard Lee; Bradley P Knight; Susan S Kim
Journal:  J Cardiovasc Electrophysiol       Date:  2012-06-14

7.  Prevalence and presentation of externalized conductors and electrical abnormalities in Riata defibrillator leads after fluoroscopic screening: report from the Netherlands Heart Rhythm Association Device Advisory Committee.

Authors:  Dominic A M J Theuns; Arif Elvan; Willem de Voogt; Carel C de Cock; Lieselot van Erven; Mathias Meine
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-10-22

8.  Detection of high incidence of Riata lead breaches by systematic postero-anterior and lateral chest X-ray in a large cohort.

Authors:  Christian Steinberg; Jean-François Sarrazin; François Philippon; Marc-André Bouchard; Gilles O'Hara; Franck Molin; Isabelle Nault; Louis Blier; Jean Champagne
Journal:  Europace       Date:  2012-11-01       Impact factor: 5.214

9.  Deaths caused by the failure of Riata and Riata ST implantable cardioverter-defibrillator leads.

Authors:  Robert G Hauser; Raed Abdelhadi; Deepa McGriff; Linda Kallinen Retel
Journal:  Heart Rhythm       Date:  2012-03-23       Impact factor: 6.343

10.  A case of riata® dual coil defibrillator lead failure in a patient with ventricular fibrillation.

Authors:  Kyu Choi; Jung Hee Kim; Hyo Jin Kim; Se-Ok Lee; Eun-Young Jang; June Soo Kim
Journal:  Korean Circ J       Date:  2013-05-31       Impact factor: 3.243

View more
  2 in total

1.  [Multiple inappropriate defibrillator shocks due to insulation failure of a Biotronik Linox defibrillator lead with externalized conductor].

Authors:  Hamdi Elfarra; Rainer Moosdorf; Leszek Rybinski; Wolfram Grimm
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-02-05

2.  Riata silicone defibrillation lead with normal electrical measures at routine ambulatory check: The role of high-voltage shock testing.

Authors:  Elia De Maria; Ambra Borghi; Lorenzo Bonetti; Pier Luigi Fontana; Stefano Cappelli
Journal:  World J Cardiol       Date:  2016-11-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.